The move adds Labcorp’s US biocompatibility, analytical testing, and preclinical research services to Namsa’s operations.

NAMSA, a global leader in medical device testing, clinical research, and regulatory consulting, is pleased to announce it has ...

Consumers Now Have More Choices to Purchase the Visby Device Featuring 30-Minute, Lab-Quality ResultsSAN JOSE, Calif.--(BUSINESS WIRE)--Today, Visby Medical announced two new relationships that will ...

Labcorp Holdings Inc. LH, or Labcorp, is well-poised to grow in the coming quarters due to its strong, consistent performance in high-growth areas. In recent years, the company has built a significant ...

A worldwide leader in injectable drug administration will be the newest company to set up shop in Greenfield, and anticipates ...

IMVARIA Inc., a health tech company pioneering AI-driven digital biomarker solutions, today announced strategic investments from new and existing investors to accelerate IMVARIA's growth and fuel ...

The dermatology CRO market specializes in providing outsourced research services that span the entire drug development ...

Future Market Insights, Inc. (FMI) is an ESOMAR-certified, ISO 9001:2015 market research and consulting organization, trusted ...

Namsa, which is backed by Archimed, has acquired Labcorp’s US-based early development medical testing business. No financial ...

Schrodinger said on Friday it is collaborating with Eli Lilly to offer the pharmaceutical major's AI-based platform, TuneLab, ...

Variant Bio, a private biotech firm, said on Tuesday it has launched a platform that uses artificial intelligence on genetic ...

Sulfolobus islandicus, an archaeal model organism, offers unique advantages for metabolic engineering and synthetic biology ...